Epstein-Barr virus (EBV) is a ubiquitous, oncogenic virus that is associated with a number of
different human malignancies as well as autoimmune disorders. The expression of EBV viral …

Epstein–Barr Virus (EBV) contributes to the development of lymphoid and epithelial
malignancies. While EBV's latent phase is more commonly associated with EBV-associated …

Epstein-Barr virus (EBV) infects cells in latent or lytic forms, but the role of lytic infection in
EBV-induced lymphomas is unclear. Here, we have used a new humanized mouse model …

Epstein–Barr virus (EBV) is a human γ-herpesvirus that infects up to 95% of the adult
population. Primary EBV infection usually occurs during childhood and is generally …

Epstein-Barr virus (EBV) is associated with roughly 10% of gastric carcinomas worldwide
(EBVaGC). Although previous investigations provide a strong link between EBV and gastric …

EBV, a member of the herpes virus family, is a paradigm for human tumor viruses and a
model of viral latency amenable for study in vitro. It induces resting human B lymphocytes to …

Latent Epstein-Barr virus (EBV) infection contributes to both B-cell and epithelial-cell
malignancies. However, whether lytic EBV infection also contributes to tumors is unclear …

Epstein Barr Virus (EBV) is one of the most common human herpesviruses. After primary
infection, it can persist in the host throughout their lifetime in a latent form, from which it can …

Epstein–Barr virus (EBV) infects up to 95% of the adult human population, with primary
infection typically occurring during childhood and usually asymptomatic. However, EBV can …

Immunosuppressed patients are at risk for developing Epstein-Barr Virus (EBV)-positive
lymphomas that express the major EBV oncoprotein, LMP1. Although increasing evidence …